Join the 'Cobicistat / elvitegravir / emtricitabine / tenofovir Alafenamide' group to help and get support from people like you.
Cobicistat / elvitegravir / emtricitabine / tenofovir Alafenamide News
Posted 20 Sep 2017 by Drugs.com
WEDNESDAY, Sept. 20, 2017 – A combination antibody strategy could be the key to halting the spread of HIV, according to results from two promising animal studies. Two separate research groups completely protected their own sets of lab monkeys from HIV infection using this combination vaccination strategy, albeit in two very different ways. One group inoculated their monkeys with a "cocktail" of ...
Posted 22 Jun 2017 by Drugs.com
WEDNESDAY, June 21, 2017 – There are mixed results from a new study on the use of monetary rewards to help boost the odds that HIV-infected patients will enter care, and take their meds as directed. The study, conducted at HIV clinics in New York City and Washington, D.C., found that financial incentives such as gift cards could improve the likelihood that HIV patients would take antiretroviral ...
Posted 31 May 2017 by Drugs.com
WEDNESDAY, May 31, 2017 – More Americans with HIV are sticking with medications that turn a fatal disease into a manageable condition, a new study shows. "This represents a lot of people who are not dying and not infecting others," said study corresponding author Ira Wilson, chair of Brown University's Health Services Policy and Practice Department, in Providence, R.I. "These differences ...
Posted 1 Dec 2016 by Drugs.com
THURSDAY, Dec. 1, 2016 – A significant number of people with HIV have strains of the AIDS-causing virus that are resistant to both older and newer drugs, researchers report. The researchers looked at 712 HIV patients worldwide whose infection was not controlled by antiretroviral drugs. They found that 16 percent of patients whose infection was resistant to modern drugs had HIV mutations linked ...
Posted 13 Jun 2016 by Drugs.com
MONDAY, June 13, 2016 – Many newly infected HIV patients experience neurological problems, but they tend to be mild and they subside after antiretroviral drugs are given, a new study finds. "We were surprised that neurologic findings were so pervasive in participants diagnosed with very recent HIV infection," said study author Dr. Joanna Hellmuth. She is a clinical fellow in the department of ...
Posted 6 May 2016 by Drugs.com
FRIDAY, May 6, 2016 – Although HIV infection and transmission rates in the United States declined over the past five years, they fell short of White House targets, a new study finds. Between 2010 and 2015, new HIV infections decreased 11 percent and transmission of the AIDS-causing virus declined 17 percent, far less than the goals set in 2010 as part of the U.S. National HIV/AIDS Strategy ...
Posted 5 Nov 2015 by Drugs.com
The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older. The CDC estimates that 1.2 million persons ages 13 years and older are living with HIV infection, and that ...
Ask a Question
Related Condition Support Groups
Related Drug Support Groups
Cobicistat / elvitegravir / emtricitabine / tenofovir Alafenamide Patient Information at Drugs.com
- Cobicistat / elvitegravir / emtricitabine / tenofovir Alafenamide Information for Consumers
- Cobicistat / elvitegravir / emtricitabine / tenofovir Alafenamide Information for Healthcare Professionals (includes dosage details)
- Side Effects of Cobicistat / elvitegravir / emtricitabine / tenofovir Alafenamide (detailed)